18 Mar Describe two common comorbidities of treatment refractory anxiety.
Follow these guidelines when completing each component of the assignment. Contact your course faculty if you have questions.
Please read the following – please note that references to DSM 5 are accurate as anxiety content was not updated in the DSM 5 TR (APA, 2023).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573566/
https://cdn.neiglobal.com/content/congress/2020/pdf-slides/C02-anxiety-syl.pdf
Answer the questions below after reviewing the full presentation.
Download the PowerPoint https://cdn.neiglobal.com/content/encore/congress/2021/slides-at-enc22-21cng-01.pdf and listen to the audio presentation https://cdn.neiglobal.com/content/encore/congress/2021/audio-at-enc22-21cng-01.mp3
Answer the questions below after reviewing the full presentation.
Treatment of anxiety can be complex. Psychiatric mental health nurse practitioners (PMHNPs) may provide care to clients with treatment-refractory anxiety.
1. Define treatment refractory anxiety.
2. Describe two common comorbidities of treatment refractory anxiety.
3. Discuss two possible approaches to treatment for treatment refractory anxiety.
4. Identify the most appropriate response to a client who states that they use marijuana to manage their anxiety. Discuss the education the PMHNP should provide.
5. Identify the most appropriate response to a client who states that they use Silexan to manage their anxiety. Discuss the education the PMHNP should provide?
